Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Tommy Martinsson

Professor

Tommy Martinsson
Professor
tommy.martinsson@clingen.gu.se

Postal Address: Avd f Klinisk Genetik, SU-Sahlgrenska,, 41345 Göteborg
Visiting Address: Madicinaregatan 3b, Vån3 , 41390 Göteborg


Department of Pathology and Genetics at Institute of Biomedicine (More Information)
SU Sahlgrenska
413 45 Göteborg
0313421000

Visiting Address: Gula stråket 2 B SU/Sahlgrenska , 413 45 Göteborg

Latest publications

Rho-associated kinase is a therapeutic target in neuroblastoma
C. Dyberg, Susanne Fransson, T. Andonova, B. Sveinbjornsson, J. Lannerholm-Palm et al.
Proceedings of the National Academy of Sciences of the United States of America, Journal article 2017
Journal article

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Jikui Guan, E. R. Tucker, Haiying Wang, Damini Chand, L. S. Danielson et al.
DMM Disease Models and Mechanisms, Journal article 2016
Journal article

The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma
D. Bogen, C. Brunner, D. Walder, A. Ziegler, R. Abbasi et al.
International Journal of Cancer, Journal article 2016
Journal article

The 1p36 Tumor Suppressor KIF 1B beta Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis
S. J. Li, S. M. Fell, O. Surova, E. Smedler, K. Wallis et al.
Developmental Cell, Journal article 2016
Journal article

Exome sequencing of an adult pituitary atypical teratoid rhabdoid tumor
S. Biswas, M. Wood, A. Joshi, N. Bown, L. Strain et al.
Frontiers in Oncology, Journal article 2015
Journal article

Showing 1 - 10 of 111

2017

Rho-associated kinase is a therapeutic target in neuroblastoma
C. Dyberg, Susanne Fransson, T. Andonova, B. Sveinbjornsson, J. Lannerholm-Palm et al.
Proceedings of the National Academy of Sciences of the United States of America, Journal article 2017
Journal article

2016

The ALK inhibitor PF-06463922 is effective as a single agent in neuroblastoma driven by expression of ALK and MYCN
Jikui Guan, E. R. Tucker, Haiying Wang, Damini Chand, L. S. Danielson et al.
DMM Disease Models and Mechanisms, Journal article 2016
Journal article

The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma
D. Bogen, C. Brunner, D. Walder, A. Ziegler, R. Abbasi et al.
International Journal of Cancer, Journal article 2016
Journal article

The 1p36 Tumor Suppressor KIF 1B beta Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis
S. J. Li, S. M. Fell, O. Surova, E. Smedler, K. Wallis et al.
Developmental Cell, Journal article 2016
Journal article

2015

Exome sequencing of an adult pituitary atypical teratoid rhabdoid tumor
S. Biswas, M. Wood, A. Joshi, N. Bown, L. Strain et al.
Frontiers in Oncology, Journal article 2015
Journal article

Showing 1 - 10 of 111

Page Manager: Webmaster|Last update: 4/19/2017
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?